Two decades of GSK rotavirus vaccine (RV1): a global analysis to estimate vaccination completion and deaths averted in children under 5 years
RV1 has contributed to reducing the number of RVGE cases and related deaths and is anticipated to continue reducing this disease burden.
Authors
- Victória Genovez
- Frederik Verelst (ORCID: https://orcid.org/0000-0001-8399-743X)
- S. Dal Col Barthès
- Olivia Berton (ORCID: https://orcid.org/0000-0001-6342-3068)
- Eliana Biundo (ORCID: https://orcid.org/0000-0002-1207-6366)
Institutions
- GlaxoSmithKline (Belgium) (BE)
- GlaxoSmithKline (India) (IN)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2025-09-22
- DOI
- https://doi.org/10.1080/14760584.2025.2564167
- Primary Topic
- Viral gastroenteritis research and epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00